Resmetirom (Rezdiffra)

Type: drug

Status: FDA Approved (first-ever for NASH)

Developer: Madrigal Pharmaceuticals

Breakthrough Summary

No summary available.

Mechanism of Action

Thyroid hormone receptor-beta agonist; first FDA-approved drug for NASH

Year: 2024